Sedoreoviridae vaccines based on truncated vp2 capsid proteins

TW202639584APending Publication Date: 2026-10-01ALTERNATIVE GENE EXPRESSION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147775
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-07
Filing Date
2025-12-05
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078695_001
    Figure TWG2TA001078695_001
  • Figure TWG2TA001078695_002
    Figure TWG2TA001078695_002
  • Figure TWG2TA001078695_003
    Figure TWG2TA001078695_003
Patent Text Reader

Abstract

The present technology relates to vaccines for the prevention or treatment of diseases resulting from an infection with a virus belonging to the Reoviridae family as well as their manufacture. The virus may belong to the Orbivirus genus, such as Epizootic Hemorrhagic disease virus (EHDV), African horse sickness virus (AHSV), Equine Encephalosis virus (EEV), and Bluetongue virus (BTV).
Need to check novelty before this filing date? Find Prior Art